|
|
|
Volumn 32, Issue SUPPL. 3, 1997, Pages 48-54
|
|
Neoadjuvant therapy prior to radiotherapy for clinically localized prostate cancer
|
|
Author keywords
Neoadjuvant hormonal radiotherapy; Radiotherapy; Total androgen suppression
|
|
Indexed keywords
ANDROGEN;
ANDROSTANOLONE;
ANTIANDROGEN;
BICALUTAMIDE;
ESTRAMUSTINE PHOSPHATE;
FLUTAMIDE;
GONADORELIN;
GOSERELIN;
LEUPRORELIN;
TESTOSTERONE;
ADJUVANT CHEMOTHERAPY;
ANIMAL MODEL;
APOPTOSIS;
CANCER RADIOTHERAPY;
DIARRHEA;
DRUG EFFICACY;
HORMONE INHIBITION;
HORMONE RELEASE;
HUMAN;
IMPLANTATION;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
PROSTATE CANCER;
REVIEW;
RISK FACTOR;
ANDROGEN ANTAGONISTS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
HUMANS;
MALE;
PROSTATE;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS;
RECEPTORS, ANDROGEN;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 0030816123
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (22)
|
|
References (34)
|
